Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonis C Antoniou

Showing results (11-20 of 319) with videos related to

Pageof 32
Sort By:
BMC Medical Informatics and Decision Making|April 12, 2012
Clinical software development for the Web: lessons learned from the BOADICEA projectAlex P Cunningham, Antonis C Antoniou, Douglas F Easton
The New England Journal of Medicine|August 25, 2017
More on Co-Occurrence of COMT and BRCA1/2 Variants in a PopulationGeorgia Chenevix-Trench, Daniel R Barnes, Antonis C Antoniou
Nature Medicine|April 20, 2022
The future of early cancer detectionRebecca C Fitzgerald, Antonis C Antoniou, Ljiljana Fruk, et al.
BJC Reports|November 8, 2024
Penetrance estimates of hereditary cancers in a population setting using UK Biobank dataRanjit Manchanda, D Gareth Evans, Antonis C Antoniou, et al.
BJC Reports|July 29, 2024
BOADICEA model: updates to the <i>BRCA2</i> breast cancer risks for ages 60 years and olderLorenzo Ficorella, Xin Yang, Douglas F Easton, et al.
Molecular Oncology|June 15, 2010
Genetic susceptibility to breast cancerNasim Mavaddat, Antonis C Antoniou, Douglas F Easton, et al.
Genetic Epidemiology|June 21, 2012
Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutationsDaniel R Barnes, Andrew Lee, , et al.
Nature Reviews. Cancer|July 21, 2023
Polygenic scores in cancerXin Yang, Siddhartha Kar, Antonis C Antoniou, et al.
Breast Cancer Research : BCR|January 19, 2006
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian familiesAntonis C Antoniou, Francine Durocher, Paula Smith, et al.
Journal of Medical Genetics|June 30, 2016
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysisRanjit Manchanda, Rosa Legood, Antonis C Antoniou, et al.
Pageof 32

Showing results (11-20 of 319) with videos related to

Sort By:
Pageof 32
BMC Medical Informatics and Decision Making|April 12, 2012
Clinical software development for the Web: lessons learned from the BOADICEA projectAlex P Cunningham, Antonis C Antoniou, Douglas F Easton
The New England Journal of Medicine|August 25, 2017
More on Co-Occurrence of COMT and BRCA1/2 Variants in a PopulationGeorgia Chenevix-Trench, Daniel R Barnes, Antonis C Antoniou
Nature Medicine|April 20, 2022
The future of early cancer detectionRebecca C Fitzgerald, Antonis C Antoniou, Ljiljana Fruk, et al.
BJC Reports|November 8, 2024
Penetrance estimates of hereditary cancers in a population setting using UK Biobank dataRanjit Manchanda, D Gareth Evans, Antonis C Antoniou, et al.
BJC Reports|July 29, 2024
BOADICEA model: updates to the <i>BRCA2</i> breast cancer risks for ages 60 years and olderLorenzo Ficorella, Xin Yang, Douglas F Easton, et al.
Molecular Oncology|June 15, 2010
Genetic susceptibility to breast cancerNasim Mavaddat, Antonis C Antoniou, Douglas F Easton, et al.
Genetic Epidemiology|June 21, 2012
Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutationsDaniel R Barnes, Andrew Lee, , et al.
Nature Reviews. Cancer|July 21, 2023
Polygenic scores in cancerXin Yang, Siddhartha Kar, Antonis C Antoniou, et al.
Breast Cancer Research : BCR|January 19, 2006
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian familiesAntonis C Antoniou, Francine Durocher, Paula Smith, et al.
Journal of Medical Genetics|June 30, 2016
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysisRanjit Manchanda, Rosa Legood, Antonis C Antoniou, et al.
Pageof 32